UCB taps new UK head. Belgium-based global biopharmaceutical company UCB welcomed Nico Reynders as its new general manager ...

As has been widely acknowledged, one of the most meaningful steps a business can take is to establish a single point of ...

Cambridge, Massachusetts-based biotech Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors for the ...

Chiesi’s strategy aligns with EU priorities on innovation, security, and private R&D investment: the decision to establish a ...

AI has the power to conduct these administrative tasks that pharmacists undertake. AI can help pharmacists intervene in a ...

The Securities & Exchange Commission (SEC) has accused Cassava's founder and former chief executive Remi Barbier and former ...

Rebecca Douglas is a strategic leader with a passion for nurturing talent. With an award-winning track record in developing ...

Flagship Pioneering's latest biotech launch, Mirai Bio, aims to help genetic medicine developers find the best way to get ...

Aqneursa has been approved to treat neurological symptoms associated with NPC in children and adults who weigh at least 15kg, ...

BMS swooped on Karuna towards the end of last year, shortly after AbbVie agreed an $8.7 billion deal to acquire Cerevel ...

Delivering the right treatment at the right time to the right patient in an affordable way is the ambition of medical affairs ...

PiaSky's approval by the MHRA earlier this year was based on the COMMODORE study, which showed that the drug was equivalent ...